Background: Gastric intestinal metaplasia (GIM) is the premalignant stage of gastric
| INTRODUCTION
Gastric cancer is a leading global health-care problem due to its high mortality. 1, 2 In Japan, the mortality rate of gastric cancer is decreasing due to curative treatment by endoscopic submucosal dissection (ESD) in early stage of gastric cancer. 3 However, the optimal early gastric cancer detection protocol in low prevalence of gastric cancer regions (5-7/100 000) has never been established. Strategies to select high-risk patient for surveillance endoscopy in daily clinical practice have been proposed. 4-9. Gastric intestinal metaplasia (GIM) is a premalignant stage in the Correa's cascade and recognised as a point of no return in this pathway. 10 However, there exists a variation, in the progression rate from GIM to gastric cancer over 5 years ranging from 0.25% to 42%. 11, 12 It is unclear whether the differences between high-, intermediate-and low-gastric cancer regions are associated with corresponding varying incidences of GIM. However, many important risk factors that may potentially affect the progression of gastric cancer in countries with moderate and high prevalence of gastric cancer have been identified and include male gender, elderly age, smoking, salty and preservative food ingestion, type of drinking water, status of H. pylori infection, family history of gastric cancer, stage of Operative Link on Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM), incomplete GIM epithelium (type II and III), serum pepsinogen I, pepsinogen II, 10, 13, 14 IL-1RN and IL-1B. [13] [14] [15] [16] [17] Unfortunately, such information on
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contributing factors in low prevalence of gastric cancer region is still very limited.
Thailand exhibits a low prevalence of gastric cancer, about 5.5/ 100 000; however, patients usually present at an advanced stage, with resulting high mortality. 18 In this study, we thus aimed to identify risk factors of gastric cancer in patients with GIM. We studied their outcomes over a long-term follow-up to better define their management in a country with low-prevalence of gastric cancer.
2 | ME TH ODS
| Setting
The retropective cohort study was started in 2010 at the King Chulalongkorn Memorial Hospital, one of the largest tertiary-care institutions in Thailand.
| Study design, patient population and data collection
The authors recruited patients with GIM diagnosed since 2004 by searching an institutional pathology database in addition to prospectively enroling patients diagnosed between 2010 and 2014. Exclusion criteria were age <18 years and a diagnosis of low-grade dysplasia, high-grade dysplasia or gastric cancer at the time of the index gastroscopy. All eligible patients with GIM were scheduled for surveillance gastroscopy at 6-12 months intervals, until completing a 5-year follow-up or when gastric cancer was observed. The surveillance gastroscopy in this study was performed by one endoscopist (R.P.) using white-light endoscopy followed by narrow-band imaging (NBI) of a suspected lesion for real-time diagnosis and targeted biopsy. The endoscopist carefully evaluated the entire stomach, including the antrum, incisura and corpus. The locations of targeted biopsies were noted in each patient's chart and photo documented.
This information was reviewed before the next follow-up gastroscopy for repeated biopsies at the same area(s) as the previously noted lesion and to exclude synchronous/metachronous lesions. All pathology slides were individually reviewed by two experienced gas- Ltd., Bangkok, Thailand) for Windows systems was used with differences considered significant at the 0.05 level. Table 1 ) Interobserver agreement of sub-type GIM reading by the two study pathologists was 85%.
| RESULTS
The data were analysed categorising the final pathology into a high-risk group that included dysplasia and cancer (N=6), and a lowrisk group comprised of diagnoses of GIM and chronic atrophic gastritis (N=85). In univariable analysis, male gender (100% vs 42.8%;
P=.027, RR=2.07) and incomplete GIM on initial pathology (83. There were no significant differences noted in other patient characteristics ( Table 2 ).
The mean level of pepsinogen I and pepsinogen I/II ratio were not significant different between high-risk and low-risk groups. The majority of patients in both groups had 1/1 locus in IL-1RN and C/C locus in IL-1B which were not different between high-and low-risk groups. Most of patients in each group had OLGA and OLGIM stage I (65%-84%) and no patient in this study belonged to stages IV of OLGA and OLGIM (Table 2) .
In multivariable analysis, only initial pathology with incomplete GIM was a significant predictor of the development of dysplastic changes or gastric adenocarcinoma (P=.034, HR=14.28, 95% CI:
1.22-166.84) after adjusting for age, smoking, alcohol, H.pylori status, preservative food consumption and family history of gastric cancer (Table 3 ).
| DISCUSSION
Two retrospective cohort studies from the USA have identified three risk factors associated with the subsequent development of gastric cancer including family history of gastric cancer, Hispanic ethnicity and extensive GIM. 5, 6 However, the sub-type of GIM which may be an important risk factor 17, 23 was not assessed. To our knowledge, this study is the first that assesses GIM sub-category as a prognostic factor of gastric adenocarcinoma in an area of low prevalence of gastric cancer over the last two decades. 12 This study revealed that the initial pathology with incomplete GIM is an important risk factor in predicting the development of high-grade dysplasia and/or gastric cancer when compared with those initially diagnosed complete GIM at baseline. The presence of incomplete GIM is already a recognised predictor of gastric adenocarcinoma in areas of high prevalence of stomach cancer such as Japan 23 and also in regions exhibiting intermediate prevalence of gastric cancer such as Spain. 17 Indeed, Uemura et al. reported higher 17 Both studies concluded that the incomplete GIM subtype identifies patients at high risk of developing gastric cancer and suggested they require intensive surveillance.
17,23
A set of guidelines endorsed by multiple societies in Europe suggest that surveillance endoscopy should only be performed in patients with extensive/severe atrophy or GIM. 9 This group does not consider subtyping of GIM (incomplete GIM or complete GIM) when considering the need for surveillance due to limited data. 9 In contrast, the American College of Gastroenterology recommends the surveillance of patients with extensive or incomplete-typed GIM. 10 Our study supports this recommendation because 83.3% ( GIM or atrophy but adopted the approach that only subtyping GIM from targeted biopsies could be a surrogate marker for early gastric cancer. In addition, male gender was another risk factor for developing high-risk gastric lesions (RR=2.07, P=.027). A large observational study completed in the UK showed that the male to female ratio was decreased in patient with gastric cancer after the age of 50-55 years, which may relate to a lack of protective hormonal levels after the reproductive stage. 24 In addition, a metaanalysis concluded that prolonged oestrogen exposure can reduce gastric cancer risk. 25 However, the protective mechanism of female hormones in gastric cancer is still unknown. 24, 25 Even if the majority of patients (87%) in our current study were over 50 years old, we lacked information to better assess any effect attributable to hormonal use.
Interestingly, we also noted that incomplete GIM can progress to high-grade dysplasia or early gastric cancer over a period extending between 6 months and 5 years from the index endoscopy. In contrast, complete GIM went on to only high-grade dysplasia at 5 years after the index endoscopy, although this occurred in only one patient which may explain the observed lack of statistical significance (P=.14). Many more patients would be needed to better confidently characterise the rate of conversion into high-risk lesions in a low gastric cancer prevalence area.
This study had certain limitations. First, the number of patients is limited. However, this study was conducted in a low prevalence area of gastric cancer, thus the number of cases was not large. Even with the limited sample size, this study is powered to demonstrate at least one significant prognostic factor with a robust hazard ratio in multivariable analysis. We can emphasise the importance of incomplete GIM on surveillance endoscopy which probably offers curative treatment in gastric cancer. Second, the number of patients with dysplasia or gastric adenocarcinoma from final pathology was not sufficient to compute the hazard ratio attributable to male gender in multivariable analysis because all six patients exhibiting high-risk pathology (dysplasia or cancer) were male (this is why we report the RR in univariable analysis instead). However, it emphasised that male gender is a strong risk factor of gastric cancer in GIM patient. Third, this study was conducted in a single institution, and although a national referral centre, the generalisability of the findings may be questioned. Fourth, subtyping GIM in this study did not use special staining techniques. This approach might be questionned in diagnosing complete GIM or incomplete GIM by some pathologists. However, Gonzalez et al. emphasised the advantage and widespread use of H&E staining on subtyping GIM in clinical practice. 17 In addition, the readings by the two pathologists in this study exhibited good interobserver agreement at 85%. These data suggest H&E staining may indeed be acceptable for distinguishing GIM sub-type in daily clinical practice, supporting such an approach in this study. Finally, the sole endoscopist in this study is an expert performing targeted biopsies under in image-enhanced endoscopy (IEE), without performing biopsy mapping of the stomach (as proposed by the updated Sydney system). 26 This practice may not be available everywhere but this biopsy protocol can target the area of interest and reduce the number of "unnecessary biopsies". It is important to note; however, that the diagnosis of GIM by IEE requires a short learning curve, providing excellent sensitivity and high accuracy. 27 Although our data would suggest that a more minimalistic approach with sole targeted biopsies may be helpful, additional studies should compare this approach to a more traditional, more extensive biopsy protocol.
| CONCLUSION S
In low prevalence of gastric cancer area, incomplete GIM and male gender are the most important risk factors associated with the development of high-grade dysplasia and early gastric adenocarcinoma. A closer surveillance interval than that put forward by existing recommendations in male incomplete GIM patients needs to be confirmed by further studies.
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